Divi’s Laboratories Limited specialises in producing active pharmaceutical ingredients and intermediates. The company is engaged in the manufacturing and custom synthesis of generic APIs and ...

This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...

Vaccines have started to trickle into the Democratic Republic of Congo after a lethal mpox outbreak, but it’s nowhere near ...

Bettersize Instruments, a leading manufacturer of particle analysis instrumentation, will host an informative webinar on ...

The Harris campaign website said the vice president is committed to bringing down drug prices "by taking on pharmacy ...

Sun Pharmaceutical Industries Ltd. 524715 shares slid 1.78% to 1,832.65 Indian rupees Wednesday, on what proved to be an ...

Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these ...

In preparation for a planned commercial rollout, Telix has contracted with Cardinal Health to enable Zircaix® 2 availability across a wide range of U.S. locations. Kevin Richardson, Chief Executive ...

Northvale, New Jersey--(Newsfile Corp. - August 27, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company ...

COPENHAGEN, Denmark and NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Ascendis Pharma Bone Diseases A/S ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

– U.S. FDA Orphan Drug exclusivity provides seven years of market exclusivity for YORVIPATH in the United States for the treatment of hypoparathyroidism in adults COPENHAGEN, Denmark, Sept. 11, 2024 ...